In metastatic brain tumors, vascular endothelial growth factor (VEGF) and metalloproteinase 2-mediated hypoxic signaling pathway may result in the loss of vascular integrity, leading to tumor-associated hemorrhage and necrosis [23,24]. The gene discussed is VEGFA; the disease is neoplasm.